|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 128.25 INR | +0.43% |
|
+2.85% | -13.55% |
| 07-09 | Camlin Fine Sciences Ownership in Vinpai Tops 95% After Cash Tender Offer | MT |
| 07-05 | Camlin Fine Sciences Limited completed the acquisition o 11.00049 % stake in Vinpai SAS for ?1.8 million. | CI |
Company Valuation: Camlin Fine Sciences Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 21,899 | 20,006 | 14,946 | 31,552 | 18,623 | 24,636 | - |
| Change | - | -8.65% | -25.29% | 111.1% | -40.98% | 32.29% | - |
| Enterprise Value (EV) | 21,899 | 20,006 | 14,946 | 31,552 | 18,623 | 24,636 | 24,636 |
| Change | - | -8.65% | -25.29% | 111.1% | -40.98% | 32.29% | 0% |
| P/E | 30.6x | 37.3x | -16x | -20.9x | 67.3x | 32.1x | 15.7x |
| PBR | - | 2.44x | 1.73x | - | 1.86x | 2.2x | 2.03x |
| PEG | - | -1.5x | 0x | -0.5x | -1x | 0x | 0x |
| Capitalization / Revenue | 1.55x | 1.19x | 0.93x | - | 1.08x | 1.15x | 1.04x |
| EV / Revenue | 0x | 0x | 0x | - | 0x | 1.15x | 1.04x |
| EV / EBITDA | 0x | 0x | 0x | - | 0x | 9.79x | 7.42x |
| EV / EBIT | 0x | 0x | -0x | - | 0x | 14.3x | 10.1x |
| EV / FCF | -0x | -0x | 0x | -0x | 0x | 300x | 14.4x |
| FCF Yield | -3.12% | -4.67% | 5.25% | -0.5% | 1.32% | 0.33% | 6.95% |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | 4.56 | 3.41 | -5.58 | -8.03 | 1.44 | 4 | 8.15 |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | 14,121 | 16,816 | 16,131 | - | 17,233 | 21,331 | 23,616 |
| EBITDA 1 | 1,528 | 2,053 | 739.2 | - | 1,069 | 2,517 | 3,318 |
| EBIT 1 | 968.4 | 1,428 | -46.91 | - | 359.6 | 1,726 | 2,430 |
| Net income 1 | 606.8 | 521.1 | -927.5 | - | 276.3 | 765 | 1,568 |
| Net Debt | - | - | - | - | - | - | - |
| Reference price 2 | 139.50 | 127.35 | 89.25 | 167.90 | 96.95 | 128.25 | 128.25 |
| Nbr of stocks (in thousands) | 156,984 | 157,093 | 167,465 | 187,921 | 192,087 | 192,092 | - |
| Announcement Date | 5/19/22 | 5/22/23 | 5/20/24 | 5/23/25 | 5/26/26 | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 31.93x | - | - | - | 257M | ||
| 36.7x | 5.01x | 20.35x | 1.05% | 78.14B | ||
| 28.98x | 4.39x | 18.95x | 2.29% | 36.85B | ||
| 24.75x | 2.95x | 15.27x | 2.11% | 36.06B | ||
| 15.9x | 1.51x | 9.2x | 1.98% | 28.07B | ||
| 38.04x | 9.34x | 28.41x | 2.4% | 23.63B | ||
| 10.19x | 2.68x | 5.61x | 3.98% | 19.15B | ||
| 26.45x | 2.75x | 11.24x | 1.95% | 18.5B | ||
| 22.98x | 2.78x | 12.76x | 1.48% | 14.02B | ||
| 11.01x | 2.34x | 5.06x | 1.38% | 13.87B | ||
| Average | 24.69x | 3.75x | 14.09x | 2.07% | 26.85B | |
| Weighted average by Cap. | 27.34x | 4.09x | 16.15x | 1.89% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CAMLINFINE Stock
- Valuation Camlin Fine Sciences Limited
Select your edition
All financial news and data tailored to specific country editions
















